The will-they, won’t-they of tariffs has been looming over the pharmaceutical industry. Earlier this week, it looked like 25% tariffs were set to be imposed on top trading partners Canada and Mexico. Then the tariffs were put on hold for a month. For the moment, that leaves only the 10% tariffs on China to contend with.
Impacts of the Chinese tariffs on the pharmaceutical industry stand to be significant. The U.S. is already struggling with...